AzTrials
AzTrials

FrailtyNCT06708494

Establishing Video Decision Aids for Geriatric Patients With Frailty to Promote Advance Care Planning

An observational study of Frailty, run by National Taiwan University Hospital at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this observational study aimed to develop and assess a video decision aid for advance care planning in geriatric patients with frailty. The main question it aims to answer is: The video decision aid comprehensibility, usability, feasibility? The video includes an introduction to geriatric frailty (3… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Frailty
What is being tested?
video decision aids
How many people
60 participants
Where
1 siteTaiwan
Study dates
19 Nov 2024to 31 Mar 2025
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: National Taiwan University Hospital inpatient wards or the Department of Family Medicine's Geriatric Frailty Clinic.

Who may be able to join

  • Phase 1 - Patients
  • Aged 65 or older.
  • Have not completed an advance directive (AD) document.
  • Able to communicate in Mandarin or Taiwanese.
  • Have adequate vision and hearing to watch a video in Mandarin or Taiwanese on a tablet.
  • Willing to participate in the study after explanation.
Show all 28Show fewer
  • Phase 1 - Family Members
  • Aged 18 or older.
  • Have not completed an advance directive (AD) document.
  • Able to communicate in Mandarin or Taiwanese.
  • Have adequate vision and hearing to watch a video in Mandarin or Taiwanese on a tablet.
  • Willing to participate in the study after explanation.
  • Phase 1 - Healthcare Providers
  • Have not completed an advance directive (AD) document.
  • Able to communicate in Mandarin or Taiwanese.
  • Willing to participate in the study after explanation.
  • Phase 2 - Patients
  • Aged 65 or older.
  • Have participated in shared decision-making (SDM) using decision aid tools.
  • Have experience in advance care planning (ACP) consultation or have completed related written advance directive documents.
  • Able to communicate in Mandarin or Taiwanese.
  • Have adequate vision and hearing to watch a video in Mandarin or Taiwanese on a tablet.
  • Willing to participate in the study after explanation.
  • Phase 2 - Healthcare Providers
  • Have professional knowledge and practical experience in advance care planning (ACP).
  • Have experience caring for frail elderly populations.
  • Able to communicate in Mandarin or Taiwanese.
  • Willing to participate in the study after explanation.

Who cannot join

  • 1.Cognitive impairment, unable to communicate clearly.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • National Taiwan University Hospital

    Taipei

Other trials in Taiwan

About this study

Official title: Establishing Video Decision Aids for Geriatric Patients With Frailty to Promote Advance Care Planning: Comprehensibility, Usability, Feasibility

The goal of this observational study aimed to develop and assess a video decision aid for advance care planning in geriatric patients with frailty. The main question it aims to answer is:

The video decision aid comprehensibility, usability, feasibility? The video includes an introduction to geriatric frailty (3 minutes) and advance care planning (5 minutes). Advance care planning includes three levels of medical care: life-prolonging care, limited care, and comfort care.

Conditions
Frailty
Being tested
video decision aids
Keywords
Frailty, Advance Care Planning, Video Decision Aids
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • video decision aidsBehavioural

    The video includes an introduction to geriatric frailty (3 minutes) and ACP (5 minutes). ACP includes three levels of medical care: life-prolonging care, limited care, and comfort care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. comprehensibility

    Comprehensibility was measured using a knowledge questionnaire and the Patient Education Materials Assessment Tool for Audiovisual Materials (PEMAT-A/V).The knowledge questionnaire consists of 7 questions, each with 10 correct answer choices, scored at 10 points per correct choice, for a total of 100 points. Higher scores indicate greater accuracy in knowledge and better comprehension. The PEMAT-A/V evaluates comprehension through 13 items and feasibility through 4 items. Responses are scored as Agree = 1 point, Disagree = 0 points, and Not Applicable (N/A) excluded from the total score calculation. The final score is calculated as Total Points/Total Possible Points x 100. Higher scores indicate that the material is easier to comprehend or more feasibility.

    Measurement timing: elder patients and their family members will complete the knowledge questionnaire before viewing the video. They will also complete the PEMAT A/V within one hour after viewing the materials.

    Measured: Watching a 10-minute video and completing questionnaire takes approximately 5-10 minutes.

  2. usability

    Usability was evaluated through a feedback questionnaire. The feedback questionnaire consists of 6 items. Except for the final open-ended question, the remaining items are scored using a 4-point Likert scale (0-3). Lower scores indicate higher usability.

    Measurement timing: elder patients and their family members will complete the feedback questionnaire within one hour after viewing the materials.

    Measured: Watching a 10-minute video and completing questionnaire takes approximately 5-10 minute

  3. feasibility

    Feasibility were evaluated through the PEMAT-A/V. The PEMAT-A/V evaluates comprehension through 13 items and feasibility through 4 items. Responses are scored as Agree = 1 point, Disagree = 0 points, and Not Applicable (N/A) excluded from the total score calculation. The final score is calculated as Total Points/Total Possible Points x 100. Higher scores indicate that the material is easier to comprehend or more feasibility.

    Measurement timing: elder patients and Healthcare professionals (Have experience in advance care planning) will complete the PEMAT A/V within one hour after viewing the materials.

    Measured: Watching a 10-minute video and completing questionnaire takes approximately 5-10 minute

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Nov 2024
  2. Study start19 Nov 2024
  3. Primary completion31 Mar 2025 (estimated)
  4. Study completion31 Mar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
60 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT06708494
Sponsor's protocol ID
202403006RIFC
Status last verified
Mar 2024
First submitted
20 Nov 2024
Last updated
27 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Frailty, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 28 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

comprehensibility (time frame: Watching a 10-minute video and completing questionnaire takes approximately 5-10 minutes.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in